Literature DB >> 25205367

Place conditioning to apomorphine in rat models of Parkinson's disease: differences by dose and side-effect expression.

Joannalee C Campbell1, Shiveindra B Jeyamohan2, Priscilla De La Cruz2, Nita Chen2, Damian Shin1, Julie G Pilitsis3.   

Abstract

One potential complication of treating Parkinson's Disease (PD) with dopaminergic drugs is dopamine dysregulation syndrome, an addiction-like response to the drug therapy. Here, we assessed whether rats given parkinsonian-like symptoms with a unilateral injection of 6-hydroxydopamine into the medial forebrain bundle (6-OHDA-MFB), exhibit similar behavior. To examine this, we injected these rats or sham-lesioned rats subcutaneously (sc) with apomorphine (APO) at low (0.05mg/kg) and high (1mg/kg) dosage and monitored their conditioned place preference Saline was administered on alternating days. After 4 and 8 conditioned pairings, both rat groups underwent post-conditioning tests in a drug-free state 6-OHDA rats exhibited positive place conditioning to the low dose of APO after 4 and 8 pairings whereas sham-lesioned rats did not (p<0.01). At the high APO dose, sham-lesioned rats showed consistent positive place conditioning, but preferences in 6-OHDA rats were more variable although they all exhibited rotation behavior. Upon further inspection, we noted that contraversive rotation increased over time and this negatively correlated with place conditioning scores. While the absolute number of rotations did not negatively affect preference for the APO-paired chamber, an increase in rotation numbers between pairings did (r=-0.634, p=0.027). Taken together, 6-OHDA rats were more sensitive to the rewarding aspects of APO, but the adverse consequence of rotation diminished this response This model may be ideal to study addiction-like responses in PD.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6-hydroxydopamine; Dopamine agonist; Dopamine dysregulation syndrome; Hemiparkinsonian

Mesh:

Substances:

Year:  2014        PMID: 25205367     DOI: 10.1016/j.bbr.2014.09.002

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  6 in total

Review 1.  Dopamine and addiction: what have we learned from 40 years of research.

Authors:  Marcello Solinas; Pauline Belujon; Pierre Olivier Fernagut; Mohamed Jaber; Nathalie Thiriet
Journal:  J Neural Transm (Vienna)       Date:  2018-12-19       Impact factor: 3.575

Review 2.  Impulse control disorders in Parkinson's disease.

Authors:  Ana Marques; Franck Durif; Pierre-Olivier Fernagut
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

3.  Pramipexole induced place preference after L-dopa therapy and nigral dopaminergic loss: linking behavior to transcriptional modifications.

Authors:  Simon Loiodice; Poppy Winlow; Sarah Dremier; Etienne Hanon; David Dardou; Omar Ouachikh; Aziz Hafidi; Andre Nogueira da Costa; Franck Durif
Journal:  Psychopharmacology (Berl)       Date:  2016-09-10       Impact factor: 4.530

4.  Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson's Disease.

Authors:  Miguel M Carvalho; Filipa L Campos; Mariana Marques; Carina Soares-Cunha; Nikolaos Kokras; Christina Dalla; Hugo Leite-Almeida; Nuno Sousa; António J Salgado
Journal:  Front Behav Neurosci       Date:  2017-08-08       Impact factor: 3.558

5.  Memantine increases NMDA receptor level in the prefrontal cortex but fails to reverse apomorphine-induced conditioned place preference in rats.

Authors:  Ziphozethu Ndlazi; Oualid Abboussi; Musa Mabandla; Willie Daniels
Journal:  AIMS Neurosci       Date:  2018-09-21

6.  Antioxidant Effect of Alpha-Lipoic Acid in 6-Hydroxydopamine Unilateral Intrastriatal Injected Rats.

Authors:  Pavlina Andreeva-Gateva; Lubomir Traikov; Zafer Sabit; Dimitar Bakalov; Radka Tafradjiiska-Hadjiolova
Journal:  Antioxidants (Basel)       Date:  2020-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.